- Home
- PHVS vs MFA Comparison
PHVS vs MFA Comparison
Compare PHVS & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- MFA
- Stock Information
- Founded
- PHVS 2015
- MFA 1997
- Country
- PHVS Netherlands
- MFA United States
- Employees
- PHVS N/A
- MFA N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- MFA Real Estate Investment Trusts
- Sector
- PHVS Health Care
- MFA Real Estate
- Exchange
- PHVS Nasdaq
- MFA Nasdaq
- Market Cap
- PHVS 1.0B
- MFA 1.1B
- IPO Year
- PHVS 2021
- MFA N/A
- Fundamental
- Price
- PHVS $22.29
- MFA $11.15
- Analyst Decision
- PHVS Buy
- MFA Buy
- Analyst Count
- PHVS 6
- MFA 5
- Target Price
- PHVS $35.67
- MFA $13.40
- AVG Volume (30 Days)
- PHVS 67.6K
- MFA 1.1M
- Earning Date
- PHVS 11-13-2024
- MFA 11-06-2024
- Dividend Yield
- PHVS N/A
- MFA 12.54%
- EPS Growth
- PHVS N/A
- MFA N/A
- EPS
- PHVS N/A
- MFA 1.60
- Revenue
- PHVS N/A
- MFA $366,192,000.00
- Revenue This Year
- PHVS N/A
- MFA N/A
- Revenue Next Year
- PHVS N/A
- MFA $17.05
- P/E Ratio
- PHVS N/A
- MFA $6.97
- Revenue Growth
- PHVS N/A
- MFA 164.50
- 52 Week Low
- PHVS $15.37
- MFA $10.20
- 52 Week High
- PHVS $33.00
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- PHVS 54.95
- MFA 35.60
- Support Level
- PHVS $18.81
- MFA $10.79
- Resistance Level
- PHVS $21.85
- MFA $11.10
- Average True Range (ATR)
- PHVS 1.44
- MFA 0.27
- MACD
- PHVS -0.17
- MFA -0.04
- Stochastic Oscillator
- PHVS 52.81
- MFA 15.50
About PHVS Pharvaris N.V.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.